Effects of “Shenqi No.1 Prescription” on insulin resistance and urinary microalbumin in early diabetic kidney disease

WANG Qi; QU Xiaolu

doi:10.16305/j.1007-1334.2018.07.014

您当前的位置：

首页 >

文章列表页 >

Effects of “Shenqi No.1 Prescription” on insulin resistance and urinary microalbumin in early diabetic kidney disease

更新时间：2022-08-31

- Effects of “Shenqi No.1 Prescription” on insulin resistance and urinary microalbumin in early diabetic kidney disease
- Shanghai Journal of Traditional Chinese Medicine Vol. 52, Issue 7, Pages: 52-54(2018)
- 作者机构：
  
  1. 上海市浦东新区浦南医院肾病科,上海,200125
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2018.07.014
  CLC：
扫描看全文
WANG Qi, QU Xiaolu. Effects of “Shenqi No.1 Prescription” on insulin resistance and urinary microalbumin in early diabetic kidney disease. [J]. Shanghai Journal of Traditional Chinese Medicine 52(7):52-54(2018)
DOI：

WANG Qi, QU Xiaolu. Effects of “Shenqi No.1 Prescription” on insulin resistance and urinary microalbumin in early diabetic kidney disease. [J]. Shanghai Journal of Traditional Chinese Medicine 52(7):52-54(2018) DOI： 10.16305/j.1007-1334.2018.07.014.

摘要

目的：观察肾芪1号方联合西医常规治疗早期糖尿病肾病的临床疗效。方法：将89例早期糖尿病肾病患者随机分为治疗组(45例)与对照组(44例)。对照组予西医常规治疗,治疗组在对照组治疗措施基础上加服肾芪1号方治疗。两组疗程均为6个月,观察空腹血糖(FPG)、餐后2 h血糖(2 hPG)、糖化血红蛋白(HbA1c)、胰岛素抵抗指数(Homa-IR)及尿微量白蛋白含量(mAlb)、血肌酐(Scr)、肾小球滤过率(eGFR)等指标的变化情况。结果：①=1\*GB3\*MERGEFORMAT治疗前后组内比较,治疗组2 hPG、HbA1c、Homa-IR水平差异有统计学意义(P<0.05),对照组血糖各项指标水平差异无统计学意义(P>0.05)。组间治疗后比较,Homa-IR水平差异有统计学意义(P<0.05)。②=2\*GB3\*MERGEFORMAT治疗前后组内比较,治疗组mAlb水平差异有统计学意义(P<0.05)。组间治疗后比较,治疗组mAlb水平明显低于对照组(P<0.05)。结论：在糖尿病肾病早期阶段采用肾芪1号方联合西医常规治疗,可改善胰岛素抵抗从而稳定血糖,保护肾脏功能,从而延缓疾病进展,改善患者的预后。

Abstract

Objective:To observe the clinical efficacy of “Shenqi No.1 Prescription” combined with routine treatment of western medicine in the treatment of early diabetic kidney disease(DKD). Methods89 patients with early DKD patients were randomly divided into the treatment group(45 cases) and control group(44 cases). The control group was treated with the routine treatment of western medicine,the treatment group was treated with “Shenqi No.1 Prescription” based on the treatment for the control group,with a course of 6 months. The changes on the indexes such as fasting plasma glucose(FPG),2 h postprandial glucose(2hPG),glycosylated hemoglobin(HbA1c),homeostasis model assessment of insulin resistance(Homa-IR),urinary microalbumin(mALB),serum creatinine(Scr) and glomerular filtration rate(eGFR) were observed. Results:①Compared with treatment before,there were statistically significant differences on the levels of 2hPG,HbA1c and Homa-IR in the treatment group after treatment(P<0.05),but no statistically significant differences on all the glycemic indexes in the control group were observed after treatment(P>0.05). After treatment, there was statistically significant difference on Homa-IR level between the two groups(P<0.05). ②Compared with treatment before,there was statistically significant difference on the mALB level in the treatment group after treatment(P<0.05). After treatment,the mALB level in the treatment group was obviously lower than that in the control group(P<0.05). Conclusion:“Shenqi No.1 Prescription” combined with routine treatment of western medicine in the treatment of early diabetic kidney disease can improve the insulin resistance, stabilize the blood glucose,protect the renal function, and thus delay the disease progression and ameliorate the prognosis of patients.

关键词

糖尿病慢性肾脏疾病肾芪1号方血糖肾功能

Keywords

diabeteschronic kidney disease“Shenqi No.1 Prescription”blood glucoserenal function

references

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical study on treatment of severe non‑proliferative diabetic retinopathy with modified Taohong Siwu Decoction and laser therapy

Precision traditional Chinese herbal medicines from the perspective of precision medicine

Experimental research progress of Dendrobium nobile Lindl. in the treatment of diabetes and its related diseases

Advances in mechanism research of anti-diabetic traditional Chinese medicine from spleen in inhibiting hepatic gluconeogenesis

Clinical study on the effect of Shenshuai Ⅱ Decoction on chronic kidney diseases 3-4 stages patients with mild-to-moderate proteinuria

Related Author

No data

Related Institution

Affiliated Hospital of Qingdao Binhai University

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Henan University of Chinese Medicine

Clinical Research Institute of Integrated Chinese and Western medicine， Shanghai Academy of Traditional Chinese Medicine

Department of Ophthalmology， Yueyang Hospital of Integrated Chinese and Western Medicine， Shanghai University of Traditional Chinese Medicine

⁰